Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIOCIGUAT for Pulmonary hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,837 adverse event reports in the FDA FAERS database where RIOCIGUAT was used for Pulmonary hypertension.

Most Reported Side Effects for RIOCIGUAT

Side Effect Reports % Deaths Hosp.
Death 4,500 24.6% 4,498 956
Dyspnoea 2,881 15.8% 443 1,875
Headache 2,462 13.5% 169 1,125
Dizziness 2,208 12.1% 156 1,060
Hypotension 2,192 12.0% 253 1,288
Nausea 2,020 11.1% 189 1,061
Hospitalisation 1,864 10.2% 346 1,859
Diarrhoea 1,790 9.8% 171 939
Fatigue 1,638 9.0% 153 851
Vomiting 1,124 6.2% 118 688
Oedema peripheral 1,018 5.6% 154 601
Peripheral swelling 1,011 5.5% 117 567
Fluid retention 916 5.0% 144 669
Cough 890 4.9% 82 497
Dyspepsia 859 4.7% 43 341

Other Indications for RIOCIGUAT

Pulmonary arterial hypertension (9,158) Product used for unknown indication (3,590) Pulmonary embolism (48) Cor pulmonale chronic (41) Heritable pulmonary arterial hypertension (27) Connective tissue disorder (18) Heart disease congenital (16) Systemic scleroderma (13) Idiopathic pulmonary fibrosis (12) Scleroderma (12)

Other Drugs Used for Pulmonary hypertension

AMBRISENTAN (18,885) TREPROSTINIL (10,034) MACITENTAN (5,228) SILDENAFIL (3,761) SELEXIPAG (2,500) EPOPROSTENOL (2,486) TADALAFIL (2,430) BOSENTAN (2,337) ILOPROST (1,123) LETAIRIS (854)

Related Pages

RIOCIGUAT Full Profile All Pulmonary hypertension Drugs RIOCIGUAT Demographics RIOCIGUAT Timeline